We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+3.51%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$16.7B
AUM Growth
-$274M
(-1.6%)
Cap. Flow
-$636M
Cap. Flow
% of AUM
-3.81%
Top 10 Holdings %
Top 10 Hldgs %
16.19%
Holding
371
New
48
Increased
82
Reduced
161
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$191M |
| 2 |
IBM
IBM
|
+$130M |
| 3 |
AEGR
Aegerion Pharmaceuticals
AEGR
|
+$101M |
| 4 |
Oracle
ORCL
|
+$94.7M |
| 5 |
EMC
EMC CORPORATION
EMC
|
+$92.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$155M |
| 2 |
BorgWarner
BWA
|
+$125M |
| 3 |
Alkermes
ALKS
|
+$119M |
| 4 |
Best Buy
BBY
|
+$101M |
| 5 |
Johnson Controls International
JCI
|
+$98.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.75% |
| 2 | Industrials | 15.57% |
| 3 | Technology | 12.88% |
| 4 | Consumer Discretionary | 10.58% |
| 5 | Communication Services | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.89T
| $391M | 2.34% |
20,388,032
+4,173,288
| +26% | +$79.4M |
|
2
Alphabet (Google) Class C
GOOG
$3.9T
| $383M | 2.29% |
13,790,055
-446,950
| -3% | -$13M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $308M | 1.84% |
1,495,390
-100,115
| -6% | -$19.8M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $300M | 1.8% |
4,300,948
-87,956
| -2% | -$6.97M |
|
5
Teva Pharmaceuticals
TEVA
$35.9B
| $260M | 1.55% |
4,912,363
-261,676
| -5% | -$12.1M |
|
6
Thermo Fisher Scientific
TMO
$211B
| $238M | 1.42% |
1,977,904
-46,015
| -2% | -$5.47M |
|
7
Visa
V
$677B
| $217M | 1.3% |
4,029,084
-123,900
| -3% | -$6.89M |
|
|
8
Jazz Pharmaceuticals
JAZZ
$15.9B
| $209M | 1.25% |
1,509,930
+1,271,735
| +534% | +$191M |
|
9
Booking.com
BKNG
$138B
| $202M | 1.21% |
4,238,600
-137,125
| -3% | -$6.77M |
|
|
CBST
10
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $197M | 1.18% |
2,698,235
-5,284
| -0.2% | -$394K |
|
11
Cooper Companies
COO
$13.7B
| $194M | 1.16% |
5,645,852
-131,928
| -2% | -$4.23M |
|
12
Bristol-Myers Squibb
BMY
$127B
| $186M | 1.11% |
3,574,014
-79,922
| -2% | -$4.25M |
|
13
Ametek
AME
$55.5B
| $185M | 1.11% |
3,595,706
-105,046
| -3% | -$5.44M |
|
|
TYC
14
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $182M | 1.09% |
4,093,042
+751,123
| +22% | +$32.8M |
|
15
RTX Corp
RTX
$287B
| $176M | 1.05% |
2,391,588
-306,173
| -11% | -$22M |
|
|
PCP
16
DELISTED
PRECISION CASTPARTS CORP
PCP
| $174M | 1.04% |
689,199
+116,823
| +20% | +$30.2M |
|
17
Salesforce
CRM
$134B
| $174M | 1.04% |
3,049,430
-288,766
| -9% | -$17.3M |
|
|
ANDV
18
DELISTED
Andeavor
ANDV
| $173M | 1.03% |
3,413,181
-419,835
| -11% | -$21.8M |
|
19
Hershey
HSY
$35.4B
| $169M | 1.01% |
1,615,835
-49,642
| -3% | -$5.08M |
|
20
Comcast
CMCSA
$79.7B
| $169M | 1.01% |
6,738,044
+623,214
| +10% | +$16.2M |
|
21
American International
AIG
$41.9B
| $166M | 0.99% |
3,318,961
-99,308
| -3% | -$4.94M |
|
|
MON
22
DELISTED
Monsanto Co
MON
| $165M | 0.99% |
1,449,359
+169,169
| +13% | +$18.8M |
|
23
Mondelez International
MDLZ
$77.7B
| $158M | 0.95% |
4,582,713
-141,700
| -3% | -$4.84M |
|
24
Halliburton
HAL
$27.9B
| $157M | 0.94% |
2,667,475
-90,851
| -3% | -$4.85M |
|
25
CNX Resources
CNX
$4.85B
| $153M | 0.91% |
4,590,976
+665,799
| +17% | +$21.5M |
|
Similar funds
OAG
JG
CHP
SAM
Westfield Capital Management's Q1 2014 Portfolio in Review
As of Q1 2014, Westfield Capital Management held 371 positions worth $16.7B, down 1.6% from $17B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Westfield Capital Management withdrew a net $636M in Q1 2014, closing 47 positions and reducing 161 holdings. Its most notable exit was Best Buy, an estimated $101M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.
Against the trend, Westfield Capital Management opened a new position in Aegerion Pharmaceuticals worth $79.3M.
- Westfield Capital Management's largest Q1 2014 buy was Aegerion Pharmaceuticals: 1,716,355 shares worth $79.3M.
- Westfield Capital Management added most to Jazz Pharmaceuticals in Q1 2014, an estimated $191M increase.
- Westfield Capital Management's biggest Q1 2014 reduction was Amazon, cutting an estimated $155M.
- Westfield Capital Management fully exited Best Buy in Q1 2014, selling an estimated $101M.
- Westfield Capital Management's ten largest holdings make up 16% of its $16.7B portfolio in Q1 2014.
- Westfield Capital Management opened 48 new positions and closed 47 in Q1 2014.
- Westfield Capital Management's portfolio value fell 1.6% quarter-over-quarter to $16.7B.
Based on Westfield Capital Management's 13F filing for Q1 2014, filed 12 May 2014.